Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127781661 | 12778166 | 1 | I | 20160915 | 20160925 | 20160925 | EXP | PHHY2016US127758 | SANDOZ | BENJAMIN LASH D, JOLLIFF J, MUNOZ A, HEIDARI A. CROSS-REACTIVITY BETWEEN VORICONAZOLE, FLUCONAZOLE AND ITRACONAZOLE. JOURNAL OF CLINICAL PHARMACY + THERAPEUTICS. 2016;41(5):566-7 | 41.00 | YR | M | Y | 0.00000 | 20160926 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127781661 | 12778166 | 1 | PS | ITRACONAZOLE. | ITRACONAZOLE | 1 | Unknown | 76104 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127781661 | 12778166 | 1 | Coccidioidomycosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127781661 | 12778166 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127781661 | 12778166 | Condition aggravated | |
| 127781661 | 12778166 | Rash maculo-papular | |
| 127781661 | 12778166 | Skin exfoliation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |